P067: Silent risks: Sudden cardiac death in a pediatric patient with MELAS
Given his initial lack of cardiac and neurological symptoms, the patient’s management plan primarily focused on routine surveillance for MELAS-related complications. The family discussed supplement options with the care team, including carnitine, creatinine, and coenzyme Q10. A follow up appointment was made to review urine sediment heteroplasmy levels once they were available.
Authors
- Sidney Sussman
- Robert Wallerstein (ORCID: https://orcid.org/0000-0003-2102-7950)
- Vinaya Murthy
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Genetics in Medicine Open
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gimo.2025.102911
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00